Imidazole → 5(S)-(Boc-Amino)-4(S)-(tert-butyldimethylsilyloxy)-6-(p-benzyloxyphenyl)-2(R)-[(p-methoxyphenyl)methyl]hexanoic acid

2.5 g (4.54 mmol) of 5(S)-(Boc-amino)-4(S)-hydroxy-6-(p-benzyloxy-phenyl)-2(R)-[(p-methoxyphenyl)methyl]hexanoic acid in 42 ml of DMF are silylated, under a protective gas, with 3.15 g (20.9 mmol) of tert-butyldimethylchlorosilane and 2.53 g (37.3 mmol) of imidazole at RT for 20 h. The reaction mixture is diluted with ethyl acetate, and this mixture is washed with sat. NaHCO3 solution, water and saline. The aqueous phases are exitacted 2× with ethyl acetate, and the organic phases are dried with Na2SO4 and evaporated. The residue is dissolved in 50 ml of methanol and 13 ml of THF, and this solution is treated with 3.8 g of potassium carbonate and 13 ml of water, and stirred at RT for 1 h. Subsequently, the reaction mixture is partially evaporated and the residue is diluted with ice-cold 10% citric acid solution; this mixture is then extracted 3× with ethyl acetate. The organic phases are washed with 2 portions of water and saline, dried with Na2SO4 and evaporated. Column chromatography (SiO2, hexane/ethyl acetate, 2:1) results in the pure title compound: TLC Rf (C)=0,13; tRet (II)=21.7 min.

1. washthis mixture is washed with sat. NaHCO3 solution, water and saline
2. dry with materialthe organic phases are dried with Na2SO4
3. customevaporated
4. dissolutionThe residue is dissolved in 50 ml of methanol
5. addition13 ml of THF, and this solution is treated with 3.8 g of potassium carbonate and 13 ml of water
6. customSubsequently, the reaction mixture is partially evaporated
7. additionthe residue is diluted with ice-cold 10% citric acid solution
8. extractionthis mixture is then extracted 3× with ethyl acetate
9. washThe organic phases are washed with 2 portions of water and saline
10. dry with materialdried with Na2SO4
11. customevaporated

ORD 기록

ord-7597b8caf5e247b490e54dbbab85e158

출처 데이터셋

uspto-grants-1997_09

DOI

10.6084/m9.figshare.5104873.v1

특허 번호

US05663200